Photodynamic Therapy for Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis | Zendy

Lin Jiao | Zendy; Guangcheng Ni | Zendy; Tingting Ding | Zendy; Shangxue Lei | Zendy; Liang Zhong | Zendy; Na Liu | Zendy; Keran Pan | Zendy; Ting Chen | Zendy; Xin Zeng | Zendy; Hao Xu | Zendy; Taiwen Li | Zendy; Hongxia Dan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Photodynamic Therapy for Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

Author(s) -

Lin Jiao,

Guangcheng Ni,

Tingting Ding,

Shangxue Lei,

Liang Zhong,

Na Liu,

Keran Pan,

Ting Chen,

Xin Zeng,

Hao Xu,

Taiwen Li,

Hongxia Dan

Publication year - 2021

Publication title -

international journal of photoenergy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.426

H-Index - 51

eISSN - 1687-529X

pISSN - 1110-662X

DOI - 10.1155/2021/6641358

Subject(s) - photodynamic therapy , meta analysis , medicine , confidence interval , basal cell , subgroup analysis , regimen , complete response , oncology , photosensitizer , lesion , gastroenterology , surgery , chemotherapy , chemistry , organic chemistry

To assess the efficacy of photodynamic therapy (PDT) for oral squamous cell carcinoma (OSCC), literature on this topic from Embase, PubMed, and Web of Science were obtained and analyzed. The response and recurrence rates with 95% confidence intervals (CI) were calculated using the DerSimonia–Laird method. The pooled complete response (CR) rate from the included studies was 0.799 (95% CI: 0.708–0.867), while the overall response (OR) rate was 0.967 (95% CI: 0.902–0.989). The recurrence rate (RR) was 0.158 (95% CI: 0.090–0.264). A subgroup analysis of lesion site, photosensitizer, laser type, radiant exposure, and power density revealed no statistically significant differences. In general, PDT is effective for the treatment of early OSCC. Investigations on the influence of PDT on the survival of OSCC patients, optimization of the treatment regimen, and evaluation of response after treatment are still needed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research